Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 181 entries
View as:

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Phase: N/A Priority: Normal
NCT ID: NCT05462535 Org: User:
Start: 02/26/18 End: 07/15/21 Due: 07/15/22

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01521455 Org: User:
Start: 02/29/12 End: 07/31/13 Due: 07/31/14

Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients

Phase: N/A Priority: Normal
NCT ID: NCT01822340 Org: User:
Start: 10/31/11 End: 02/29/16 Due: 02/28/17

A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04087525 Org: User:
Start: 10/23/18 End: 11/27/18 Due: 11/27/19

A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

Phase: N/A Priority: Normal
NCT ID: NCT01929070 Org: User:
Start: 02/28/13 End: 03/31/13 Due: 03/31/14

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Phase: N/A Priority: Normal
NCT ID: NCT02916602 Org: User:
Start: 04/30/15 End: 09/30/16 Due: 09/30/17

Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04652349 Org: User:
Start: 07/06/20 End: 01/14/21 Due: 01/14/22

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT04322266 Org: User:
Start: 12/21/18 End: 02/13/19 Due: 02/13/20

Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04252872 Org: User:
Start: 08/31/15 End: 11/30/15 Due: 11/30/16

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03826641 Org: User:
Start: 02/01/19 End: 04/16/19 Due: 04/16/20

Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT04830449 Org: User:
Start: 10/29/20 End: 08/24/21 Due: 08/24/22

Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD

Phase: N/A Priority: Normal
NCT ID: NCT02551172 Org: User:
Start: 10/31/14 End: 02/29/16 Due: 02/28/17

Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.

Phase: N/A Priority: Normal
NCT ID: NCT04654702 Org: User:
Start: 11/17/17 End: 07/20/20 Due: 07/20/21

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05155995 Org: User:
Start: 09/28/21 End: 11/27/22 Due: 11/27/23

Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions

Phase: N/A Priority: Normal
NCT ID: NCT02941731 Org: User:
Start: 04/30/15 End: 09/30/15 Due: 09/30/16

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT05024721 Org: User:
Start: 08/09/21 End: 03/07/22 Due: 03/07/23

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01127217 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude

Phase: N/A Priority: Normal
NCT ID: NCT02523547 Org: User:
Start: 01/31/15 End: 02/28/17 Due: 02/28/18

To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01864863 Org: User:
Start: 04/30/13 End: 05/31/13 Due: 05/31/14

A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05362110 Org: User:
Start: 05/16/22 End: 06/05/23 Due: 06/05/24

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04084184 Org: User:
Start: 03/15/19 End: 03/29/19 Due: 03/29/20

Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00973115 Org: User:
Start: 11/30/07 End: 08/31/09 Due: 08/31/10

Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01455584 Org: User:
Start: 06/30/11 End: 05/31/13 Due: 05/31/14

A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients

Phase: N/A Priority: Normal
NCT ID: NCT06595004 Org: User:
Start: 11/20/24 End: 06/30/25 Due: 06/30/26

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00979563 Org: User:
Start: 07/31/08 End: 11/30/10 Due: 11/30/11